Medicament (3004490040)
CN → US| HS编码 | 关税税率 | 原产国 | 目的国 | 文档 |
|---|---|---|---|---|
| 3004490040 | 10.0% | CN | US | 官方文档 |
| 3004490030 | 10.0% | CN | US | 官方文档 |
商品图片
AI分析
💊 Medicament (Drug Preparations)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 I. Product Definition & Classification: Do You Really Understand "Medicament"?
Medicament refers to any substance or preparation intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals. In international trade, pharmaceutical products are strictly regulated and classified primarily under Chapter 30 (Pharmaceutical Products) of the Harmonized System (HS).
Unlike consumer electronics, medicinal products require precise classification based on their composition (e.g., alkaloids, vitamins, antibiotics) and form (e.g., tablets, injections, powders). Misclassification can lead to severe penalties, delays, or rejection at customs due to the sensitive nature of healthcare goods.
⚠️ Key Distinction Point:
- Preparations for therapeutic/preventive use → Typically fall under 3004 (Medicaments consisting of mixed or unmixed products);
- Unmixed products for retail sale → Typically fall under 3003;
- Medical devices or supplements → May fall under Chapters 90 or 21, not Chapter 30.
📦 II. HS Code Classification Details (Based on Provided Data)
The following HS codes are derived directly from the provided dataset. All items share the same tax structure as they fall under the same tariff liability rules for Chinese-origin pharmaceuticals imported into the US (assuming standard context for "122 Clause" references).
| HS Code | Product Description | Application Scenario | Key Classification Logic |
|---|---|---|---|
3003.90.01.90 |
Medicaments (Other) | General pharmaceutical preparations not specified elsewhere; "Catch-all" for unclassified drugs in Chapter 30 | Based on residual category rules for drugs not fitting specific 3004 subheadings |
3004.49.00.50 |
Medicaments (Other) | Drugs specifically defined by therapeutic/preventive purpose matching HS code definitions | Direct alignment with therapeutic use definition; no conflict with prefix |
3004.49.00.70 |
Medicaments (Other) | Explicit drug preparations for treatment or prevention | Matches HS prefix; intended for therapeutic use; no conflicts with reference categories |
3003.49.00.00 |
Medicaments (Other) | Drug preparations containing alkaloids or other specific chemical components | Tends to match categories containing biologically active alkaloids or specific chemical entities |
🔍 Critical Reminder:
- All listed HS codes are for pharmaceutical products intended for human/animal health;
- The classification depends heavily on whether the product is mixed (3004) or unmixed (3003);
- 3004 generally covers preparations (formulated for retail sale), while 3003 covers unmixed products still in bulk or unprepared form.
💰 III. 2026 Latest Tariff Rate Breakdown (Including Additional Duties & Policy Surcharges)
✅ Applicable Country: United States (US)
✅ Origin: China (CN) (Inferred from "Section 122" and "10%" surcharge typical of US-China trade tensions)
✅ Effective Date: Ongoing (2025-2026 Period)
🎯 1. General Tariff Structure for All Listed HS Codes
| Item | Content |
|---|---|
| Basic MFN Rate | 0% (ad valorem) |
| Section 301 / Additional Tariff | 0% (No specific 301 tariff for these specific subheadings in the provided data) |
| Section 122 Tariff | +10% (Specific surcharge applied to Chinese-origin pharmaceuticals/medicaments) |
| Total Tax Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Exemption Available? | ❌ NO (Deny de minimis) — Medicaments are excluded from de minimis (Section 321) entry privileges |
| Legal Basis Path | HTSUS:3003/3004 → Section 122 Authority → US Customs Ruling |
📌 Explanation:
- "Basic Tariff: 0%": The Harmonized Tariff Schedule (HTS) base rate for many pharmaceuticals is zero or low;
- "Section 122 Tariff: 10%": This is a critical surcharge. In the context of US-China trade, this likely refers to Section 122 of the Trade Act of 1974 (presidential authority to adjust tariffs for national security/economic reasons) or a specific Executive Order/Proclamation targeting Chinese medical supplies during health emergencies;
- Total 10%: Must be paid on all imports of these medicaments;
- No De Minimis: Packages under $800 cannot avoid this tax. All shipments, regardless of value, must declare and pay the 10% duty.
🛠️ IV. Customs Clearance Practical Advice (Real-World Pitfall Avoidance Guide)
✅ 1. Required Documentation Checklist (None Can Be Missing)
| Document | Mandatory | Description |
|---|---|---|
| ✅ Commercial Invoice | ✔️ | Must clearly state "Medicament for Human/Animal Use," HS Code, Quantity, Unit Price, Total Value |
| ✅ Packing List | ✔️ | Detailed list of items, weights, dimensions, batch numbers |
| ✅ Certificate of Analysis (COA) | ✔️ | Proof of composition, active ingredients, and purity from manufacturer |
| ✅ FDA Prior Notice / Registration | ✔️ | Critical: Medicaments require FDA approval or listing. Importer must verify FDA registration number |
| ✅ Letter of Authorization | ✔️ | If importing on behalf of another entity |
| ✅ Country of Origin Certificate | ✔️ | Proves origin is China (to apply correct 10% tariff) |
🚨 Warning:
- FDA Compliance is Mandatory: Even if customs allows entry, FDA may detain the shipment if not properly registered;
- Batch/Lot Numbers: Must be clearly marked on all packages for traceability.
✅ 2. Declaration Tips (Key Rules)
🔥 "Be Precise, Be Complete, Or Face Detention!"
| Scenario | Correct Declaration | Incorrect Practice |
|---|---|---|
| Mixed Drug Preparations | Use 3004.49.xx if formulated for retail use | Misclassify as raw chemicals → Higher scrutiny |
| Unmixed Active Ingredients | Use 3003.49.00.00 if not yet prepared | Use 3004 → Misclassification risk |
| Small Shipments (<$800) | Still Declare Duty: Pay 10% via formal entry | Assume de minimis exemption → Shipment Held |
| Generic vs. Branded | Clearly state "Generic" or "Brand Name" | Vague description "Medicine" → Delay |
📌 Note:
- Section 122 Tariff applies regardless of volume;
- Do NOT use vague terms like "Supplement" or "Vitamins" if they are classified as drugs;
- Ensure HS Code matches the exact composition of the product.
✅ 3. Special Handling Cases
| Case | Handling Advice |
|---|---|
| Temperature-Sensitive Drugs | Provide proof of cold chain logistics (2-8°C); otherwise, FDA may reject |
| Controlled Substances | Require DEA license; additional fees and inspections |
| Biologicals | May fall under different HS codes (e.g., 3002); verify classification |
| Personal Use vs. Commercial | Even for personal use, if value > $800 or quantity suggests commercial, formal entry required |
🌍 V. Global Market Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff Rate | Certification Requirements | Notes |
|---|---|---|---|---|
| 🇺🇸 USA | 3004.49.00.50 / 3003.49.00.00 |
10% (China Origin) | FDA Approval + Prior Notice | Section 122 applies; No de minimis |
| 🇨🇳 China | Same HS Codes | 0% - 5% | NMPA Registration | Lower tariffs, but strict domestic regulation |
| 🇪🇺 EU | 3004 / 3003 |
0% - 6.5% | EMA Approval + CE Mark (if device) | Varies by member state; generally lower than US |
| 🇬🇧 UK | 3004 / 3003 |
0% - 4.5% | MHRA License | Post-Brexit rules apply |
| 🇯🇵 Japan | 3004 / 3003 |
0% - 4% | PMDA Approval | Strict safety standards |
📌 Conclusion:
- USA imposes a unique 10% surcharge on Chinese-origin medicaments via Section 122;
- No de minimis exemption makes small shipments costly and complex;
- FDA compliance is the biggest hurdle, often more significant than tariffs.
📌 VI. Common Errors & Pitfalls (Blood Lessons)
❌ Error 1: Assuming packages under $800 are tax-free
👉 Consequence: Shipment detained at US border; 10% duty + storage fees + penalties applied retroactively.
❌ Error 2: Using "Vitamins" or "Supplements" for drug-classified products
👉 Consequence: FDA detention; product destroyed or returned; importer blacklisted.
❌ Error 3: Incorrect HS Code (e.g., using 3003 for a prepared drug)
👉 Consequence: Misclassification penalty; audit risk; potential criminal liability for fraud.
❌ Error 4: Missing COA or Batch Number
👉 Consequence: FDA refusal of entry; entire shipment rejected.
✅ Correct Approach:
"Medicament: [Active Ingredient], [Formulation Type], for [Therapeutic Use], Batch No. [XXX], Manufactured by [Company], FDA Registered, Origin: China"
🎯 VII. Conclusion: Professional Declaration Saves Time, Money, and Ships
🎯 Remember the Mantra:
🔹 "Section 122: 10% is Fixed, De Minimis is Dead."
🔹 "FDA First, Customs Second, Classification Must Be Precise."
🔹 "No Vague Terms, No Guessing, Or Face Detention."
📌 Pro Tip:
- For shipments to the US, always verify FDA status before shipping;
- Consider customs brokerage pre-clearance for high-value or complex medicament imports;
- Keep all documentation digital and accessible for quick customs inspection.
📣 Immediate Action:
📞 Consult a licensed customs broker + Verify FDA registration + Apply for HS Code ruling if uncertain
🚀 Ensure your medicaments clear customs smoothly, avoid FDA holds, and reach your customers on time.
✨ Professional Clearance Starts with Accurate Classification!
💼 Your pharmaceutical products are high-value and high-risk; precision is your best insurance.
用户评价
关于 HS 编码归类
协调制度(HS)是由世界海关组织(WCO)制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构:
- 章(2 位)——商品大类(例如:第 84 章:机器和机械设备)
- 品目(4 位)——章内的更具体分类
- 子目(6 位)——国际通用细分,所有 WCO 成员国统一使用
- 本国细分(8-10 位)——各国自行扩展的细分编码,如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时,适用的关税税率可能包括:
- 最惠国(MFN)税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税,如 301 条款(反倾销)、232 条款(国家安全)或反补贴税
本页内容仅供参考。如需正式归类,请咨询当地海关或持牌报关代理。